Published 2013 | Version v1
Publication

Treatment with oxaprozin reduces neutrophil migration in response to C5a and CXCL8 via the inhibition of the PI3K/Akt pathway.

Additional details

Created:
March 27, 2023
Modified:
November 28, 2023